How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Vitamin Analysis Service Market
- By Service Type: Blood Vitamin Analysis, Urine Vitamin Analysis, Hair Mineral and Vitamin Analysis, Saliva Vitamin Testing, Comprehensive Micronutrient Panel
- By Vitamin Tested: Vitamin A Analysis, Vitamin B Complex Analysis, Vitamin C Analysis, Vitamin D Analysis, Vitamin E Analysis, Vitamin K Analysis
- By End User: Clinical Laboratories, Hospitals and Diagnostic Centers, Nutritional and Wellness Clinics, Research Institutions, Direct-to-Consumer Testing Services
- By Testing Methodology: High-Performance Liquid Chromatography (HPLC), Mass Spectrometry, Enzyme-Linked Immunosorbent Assay (ELISA), Spectrophotometry, Fluorometric Assays
- By Application: Nutritional Deficiency Diagnosis, Chronic Disease Management, Sports Nutrition and Performance, Prenatal and Maternal Health, Public Health Screening
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Blood Vitamin Analysis leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 308 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.187 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.195 →
Full report · locked preview
Everything inside the Vitamin Analysis Service Market report
A complete, evidence-based study - 12 chapters and 129 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Quest Diagnostics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →LabCorp
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Eurofins Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →SGS SA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →BioReference Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Mayo Clinic Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →ARUP Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Genova Diagnostics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Health Diagnostic Laboratory (HDL)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Bureau Veritas
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Synlab
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →MedLab Pathology
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Unilabs
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →ICON plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Charles River Laboratories
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Blood Vitamin Analysis39.6
- Urine Vitamin Analysis9.7
- Hair Mineral and Vitamin Analysis12.7
- Saliva Vitamin Testing19.7
- Comprehensive Micronutrient Panel18.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Quest Diagnostics24.0
- LabCorp8.3
- Eurofins Scientific8.3
- SGS SA8.6
- BioReference Laboratories10.0
- Mayo Clinic Laboratories12.7
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.2
- Europe22.6
- Asia Pacific21.0
- Latin America13.0
- Middle East and Africa9.2
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics | 91 | 93 | 92 | 93 | 92 | 92 | 92 |
| LabCorp | 81 | 86 | 69 | 80 | 76 | 70 | 77 |
| Eurofins Scientific | 65 | 80 | 81 | 86 | 83 | 68 | 77 |
| SGS SA | 58 | 66 | 79 | 57 | 57 | 75 | 65 |
| BioReference Laboratories | 65 | 61 | 72 | 57 | 61 | 58 | 62 |
| Mayo Clinic Laboratories | 58 | 59 | 49 | 49 | 62 | 63 | 57 |
| ARUP Laboratories | 46 | 55 | 43 | 51 | 54 | 65 | 52 |
| Genova Diagnostics | 39 | 35 | 60 | 47 | 45 | 60 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Quest Diagnostics
- LabCorp
- Eurofins Scientific
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Quest Diagnostics | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| LabCorp | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Eurofins Scientific | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| SGS SA | − | ◐ | ✓ | − | ◐ | ◐ |
| BioReference Laboratories | − | − | ◐ | ◐ | − | − |
| Mayo Clinic Laboratories | − | ◐ | ◐ | − | − | − |
| ARUP Laboratories | − | ◐ | − | − | − | ◐ |
| Genova Diagnostics | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender3
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Service Type in North America, then scale across Vitamin Analysis Service Market — a $477M beachhead inside a $8.20B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Blood Vitamin Analysis
Best fit — highest urgency & budget in Service Type.
Urine Vitamin Analysis
Strong fit — clear ROI and a fast path to value.
Hair Mineral and Vitamin Analysis
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Vitamin Tested & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Vitamin Analysis Service Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Vitamin Analysis Service Market is a resilient opportunity — $2.94B by 2033, compounding at 4.8%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.8% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Vitamin Tested optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Vitamin Analysis Service Market — a $5.50B market by 2033. Plan: grow share from 7.4% to 15.5%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.4% | 15.5% | On track |
| Revenue | $440M | $853M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 35.3% | 44.3% | Behind |
| Customer retention | 88.5% | 96.8% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Vitamin Tested capability
A defensible second engine — invest in Vitamin Tested to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Vitamin Tested
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $110M capacity & capability investment
- Greenlight bolt-on M&A in Vitamin Tested
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskBehind
- Regulatory / policy changeBehind
- Execution & talentOn track
Sales deck · value proposition
Win the Vitamin Analysis Service Market conversation — a $6.52B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Vitamin Analysis Service Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Vitamin Analysis Service Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Vitamin AD Drops Market
Market size, share, segmentation and regional forecast.
$763M market · 2025 base year
View reportVitamin AD Drops for Children Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportVitamin AD3 Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportVitamin A Acetate Powder Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportVitamin A Acetate Oil Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportVitamin A Acetate Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportVitamin A1 (Retinol) Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportVital Sign Telemedicine System Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportVital Signs Telemonitoring System Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportVital Signs Simulators Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportVital Signs Sensor Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportVital Signs Patient Monitor Market
Market size, share, segmentation and regional forecast.
$439M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy